Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000974 |
---|---|
Receipt number | R000001169 |
Scientific Title | A randomized phase II study designed to compare toxicity and dose intensity between four-week versus three-week schedule of gemcitabine for advanced pancreatic cancer |
Date of disclosure of the study information | 2008/01/08 |
Last modified on | 2008/01/08 19:45:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/01/08 19:47:40 |